Image may be NSFW.
Clik here to view.
Shares in Dexcom (NSDQ:DXCM) rose 4% today after the company announced a partnership with UnitedHealth (NYSE:UNH) to assess if data from a continuous glucose monitor can help people with Type II diabetes manage their condition in a cost-effective way.
UnitedHealth is slated to use CGM data, as well as diet and exercise activity, in a study of 10,000 people that will launch within the next nine months. If the initial study is successful, UnitedHealth plans to kick off a network-wide initiative, Seeking Alpha reported.
Get the full story at our sister site, Drug Delivery Business News.
The post Dexcom inks continuous glucose monitoring deal with UnitedHealth appeared first on MassDevice.
